Dawn Bravata on JAMA Network Open

Dr. Dawn Bravata interviewed on JAMA Network Open Live

Regenstrief Institute’s Dawn Bravata, M.D., an expert in stroke care, spoke to JAMA editors about her recent paper published in JAMA Network Open. The study examined the care processes associated with mortality and recurrent stroke in patients with TIA and non-severe strokes.

Dr. Bravata’s team examined 28 processes of care and defined six processes as “without-fail care” because they have been found to be effective in past studies and should be routinely available at most facilities. Those processes were: brain imaging, carotid artery imaging, hypertension medication intensification, high-moderate potency statin, antithrombotics, and anticoagulation for atrial fibrillation. Patients who received all of the processes for which they were eligible were classified as passing the “without-fail care” measure.

The study looked at more than 8,000 veterans who received VA care in an emergency or inpatient setting from October 2010 to September 2011.

The findings of the paper concluded that without-fail care — including the six readily available processes — was associated with lower odds of death but not lower recurrent stroke rates. Dr. Bravata and her team recommend healthcare systems prioritize patients with TIA or non-severe stroke and provide them with all the without-fail care processes they are eligible for.

Dr. Bravata discussed the study and its implications, answering questions from the hosts of JAMA Network Open Live. Watch the clips.

Study background and method

The key finding

The difference in quality of care for TIA and stroke

The VA has improved its quality of care since 2010/2011. What is the relevance of this data?

Seeing a neurologist within 24 hours is linked with better mortality rates

Neurologists and hypertension management

The processes are associated with lower risk of mortality but not stroke reduction

Watch the entire interview:

Read the entire paper

In addition to Regenstrief, Dr. Bravata is a core investigator at the Veterans Affairs Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center, co-principal investigator, VA HSR&D Stroke Quality Enhancement Research Initiative, and a professor at Indiana University School of Medicine.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org

Related News

Nov 15, 2019 • News
Indiana FSSA secretary joins Regenstrief Institute Board of Directors
Jennifer Sullivan, M.D., MPH, secretary of the Indiana Family and Social Services Administration (FSSA), has joined Regenstrief Institute’s Board of Directors. Regenstrief’s board provides strategic guidance, oversight and management for the internationally respected medical research organization in support of its mission to improve local, national and global delivery and outcomes of healthcare through research and…
Continue Reading >
Nov 15, 2019 • News
Turning data into action: Regenstrief scientists engage in national informatics discussion
Regenstrief Institute has been on the cutting edge of informatics for 50 years. Institute research scientists will present their latest research and lead discussions about the future applications of data, electronic health records and artificial intelligence at the American Medical Informatics Association 2019 Annual Symposium, November 16-20 in Washington, D.C. The annual meeting is the…
Continue Reading >